Del Monte Institute for Neuroscience / News & Events / ECNS 2026 / Agenda

Agenda

Day 1 \| Tuesday \| September 22, 2026
8:00 am - 8:45 am	Breakfast
8:45 am - 9:00 am	Welcome and Opening Remarks
Session 1: Neurobiologically-derived biomarkers and mechanistically targeted interventions in neurodevelopmental conditions
9:00 am – 9:30 am	Dr. Lauren Ethridge Translating sensory EEG phenotypes in Fragile X Syndrome (FXS): validating biomarkers from mouse to human to enable clinical trials
9:30 am – 10:00 am	Dr. Christine Conelea Targeted engagement of Tourette-related neurocircuitry with TMS to augment behavior therapy
10:00 am – 10:30 am	Dr. Christian Cazares Aperiodic activity as a candidate marker of cortical dysfunction in Rett syndrome EEG and Mecp2+/- mouse visual cortex
10:30 am – 10:45 am	Session 1 Discussion Panel
10:45 am - 11:00 am	Break
Session 2: Neural Oscillations and Network Synchrony: From Circuit Mechanisms to Biomarkers in Autism and Related Neurodevelopmental Disorders
11:00 am – 11:30 am	Dr. Shlomit Beker From Neural Synchrony to Clinical Biomarkers
11:30 am – 12: 00 pm	Dr. Sophie Molholm Beyond Sensory Encoding: Altered Feedback Shapes Perception in Autism
12: 00 pm – 12: 30pm	Dr. Tal Kenet Synchronization as a Window into the Neural Mechanisms Underlying Autism
12: 30 pm – 12:45 pm	Session 2 Discussion Panel
12:45 pm - 1:45 pm	Lunch
ECNS Presidential Lecture
1:45 pm - 2:15 pm	Dr. M. Kemal Arikan
Session 3: Trainee and Early Career Investigators Session
2:15 pm – 3:15 pm	Flash Talks
3:15 pm – 4:15 pm	Poster Session
Keynote Speaker
4:15 pm - 5:30 pm	Dr. Adrianna Di Martino

Day 2 \| Wednesday \| September 23, 2026
8:30 am - 9:00 am	Breakfast
Session 4: Psychosis
9:00 am – 9:30 am	Dr. Brian Keane Thalamic and cortical sensory dysconnectivity as a biomarker for psychosis
9:30 am – 10:00 am	TBA
10:00 am – 10:30 am	Dr. Steven Silverstein Retinal neural and vascular changes in psychotic and mood disorders
10:30 am – 10:45 am	Session 4 Discussion Panel
10:45 am - 11:00 am	Break
Session 5: Targeting Brain Stimulation – The When and the Where
11:00 am – 11:30 am	Dr. Ivan Alekseichuk Physiological and behavioral roles of EEG phase through the lens of transcranial magnetic stimulation
11:30 pm – 12:00 pm	Dr. Eric Rawls Using multimodal neuroimaging to isolate and target a human neurocomputational mechanism driving enhanced expected value of control
12:00 pm – 12:30 pm	Dr. Simon Davis Modulating memory representations in aging and disease
12:30 pm – 12:45 pm	Session 5 Discussion Panel
12:45 pm - 2:00 pm	Lunch
Session 6: EEG-Derived Markers to Characterize and Treat Drug Use
2:00 pm – 2:30 pm	Dr. Derek Fisher Interaction between caffeine and menstrual cycle phase on EEG-indexed sustained attention
2:30 pm – 3:00 pm	Dr. Salvatore Campanella Cognitive ERPs in substance use disorders
3:00 pm – 3:30 pm	Dr. Tanju Surmeli QEEG Guided Neurofeedback is effective and reduces relapses as a stand-alone therapy in Substance Use Disorders
3:30 pm – 3:45 pm	Session 3 Discussion Panel
3:45 pm - 4:15 pm	Break
Keynote Speaker
4:15 pm - 5:30 pm	Dr. Bernadette Gillick Understanding Recovery and Development after Early Brain Injury using Neuromodulation
6:00 pm - 9:00 pm	Dinner Reception Jackrabbit Club 40 Anderson Avenue Rochester, NY

Day 3 \| Thursday \| September 24, 2026
8:30 am - 9:00 am	Breakfast
Session 7: Bridging the Gap Between Research and Clinical Practice: Implications of Intracranial Electroencephalography
9:00 am – 9:30 am	Dr. Tonmoy Monsoor Bridging Research and Practice in Intracranial EEG: Omni-iEEG for Epilepsy Biomarker Discovery
9:30 am – 10:00 am	Dr. Adeen Flinker Neural dynamics of feedforward and feedback speech processing
10:00 am – 10:30 am	Dr. Frank Garcea Advances in translational brain mapping at URMC
10:30 am – 10:45 am	Session 7 Discussion Panel
10:45 am - 11:00 am	Break
Session 8: EEG Biomarkers of Predictive Processing in Psychosis and its At-Risk State
11:00 am – 11:20 am	Dr. Michael Kiang P2 visual semantic priming effects predict two-year clinical outcomes in patients at clinical high risk for psychosis
11:20 am – 11:40am	Dr. Molly Erickson Divergence between mismatch negativity (MMN) deficits and clinical symptoms in schizophrenia
11:40 am – 12:00 pm	Dr. Victor Pokorny Alpha Peak Frequency in Individuals at Clinical High-Risk for Psychosis
12:00 pm – 12:20 pm	Dr. Brian Coffman Effects of Attention on Perceptual Grouping and Segmentation of Auditory Stimuli in First Episode Psychosis
12:20 pm – 12:45 pm	Session 8 Discussion Panel
12:45 pm - 2:00 pm	Lunch
Session 9: Bridging the Gap Between Research and Clinical Practice: Implications of intracranial Electroencephalography
2:00 pm – 2:30 pm	Dr. Kathryn Toffolo Developing a sense of meaning: How children with and without autism comprehend semantics across development
2:30 pm – 3:00 pm	Dr. Mark Pflieger Using individual structural MRI and group fMRI to benchmark and improve distributed localization of ERP cortical sources
3:00 pm – 3:30 pm	Dr. Pierfilippo De Sanctis Neural Signatures of Complex Daily Activities in Older Adults at Risk for Cognitive Decline
3:30 pm – 3:45 pm	Session 9 Discussion Panel
3:45 pm - 4:00 pm	Break
Keynote Speaker
4:00 pm - 5:15 pm	Dr. Lisa Maffie Honoring Loss and Driving Discovery: Risk, Research, and the Fight to End SUDEP (Sudden Unexpected Death in Epilepsy)
5:15 pm - 5:20 pm	Closing remarks

For questions about the event, please email: Sherry_Mentor@URMC.Rochester.edu

For questions about the registration site or process, please email: cmeregistration@urmc.rochester.edu